Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension

Table 5

Predictive values of NLR for 3-month all-cause mortality.

	Univariable Cox regression model		Multivariable Cox regression model 1		Multivariable Cox regression model 2		Multivariable Cox regression model 3
	HR (95% CI)	value	HR (95% CI)	value	HR (95% CI)	value	HR (95% CI)	value
NLR	1.097 (1.058–1.138)	<0.001	1.091 (1.048–1.137)	<0.001	1.113 (1.050–1.180)	<0.001	1.142 (1.056–1.235)	0.001

Model 1, adjustment for age, sex, and BMI. Model 2, adjustment for Model 1 plus HT, DM, CHD, AF, BNP, and eGFR. Model 3, adjustment for Model 2 plus LAVI, LVEF, LVMI, E/e′, and peak AV velocity. NLR, neutrophil-to-lymphocyte ratio; BMI, body mass index; HT, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; AF, atrial fibrillation; BNP, B-type natriuretic peptide; eGFR, estimated glomerular filtration rate; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; E/e′, early diastolic transmitral flow velocity/lateral mitral annular myocardial velocity; AV, aortic valve.